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Three-dimensional organotypic 
matrices from alternative collagen 
sources as pre-clinical models for 
cell biology
James R. W. Conway1,2, Claire Vennin1,2, Aurélie S. Cazet1,2, David Herrmann  1,2, Kendelle J. 
Murphy1,2, Sean C. Warren  1,2, Lena Wullkopf1,2, Alice Boulghourjian1,2, Anaiis Zaratzian1,2, 
Andrew M. Da Silva1,2, Marina Pajic1,2, Jennifer P. Morton3,4, Thomas R. Cox  1,2 & Paul Timpson1,2
Organotypic co-cultures bridge the gap between standard two-dimensional culture and mouse models. 
Such assays increase the fidelity of pre-clinical studies, to better inform lead compound development 
and address the increasing attrition rates of lead compounds within the pharmaceutical industry, which 
are often a result of screening in less faithful two-dimensional models. Using large-scale acid-extraction 
techniques, we demonstrate a step-by-step process to isolate collagen I from commercially available 
animal byproducts. Using the well-established rat tail tendon collagen as a benchmark, we apply our 
novel kangaroo tail tendon collagen as an alternative collagen source for our screening-ready three-
dimensional organotypic co-culture platform. Both collagen sources showed equal applicability for 
invasive, proliferative or survival assessment of well-established cancer models and clinically relevant 
patient-derived cancer cell lines. Additional readouts were also demonstrated when comparing these 
alternative collagen sources for stromal contributions to stiffness, organization and ultrastructure via 
atomic force microscopy, second harmonic generation imaging and scanning electron microscopy, 
among other vital biological readouts, where only minor differences were found between the 
preparations. Organotypic co-cultures represent an easy, affordable and scalable model to investigate 
drug responses within a physiologically relevant 3D platform.
Cellular interactions with the extracellular matrix (ECM) occur in a three-dimensional (3D) context and this 
essential aspect of the tumour microenvironment can lead to altered sensitivity to therapeutics and even act 
as a barrier to their delivery. This key feature is often overlooked in pre-clinical studies and is likely one of the 
central factors contributing to the high attrition rates of lead compounds within the pharmaceutical indus-
try, as highlighted recently by our group and others1,2. In line with emerging 3D in vitro techniques, such as 
organoid cultures, as pre-clinical testing grounds, there is a need for broader-scale, reproducible and high 
throughput pre-clinical assays that integrate essential tumour interactions and responses with stromal and ECM 
components3–8.
Collagens are the most abundant ECM component within the body and make up the majority of all inter-
stitial matrix. Despite their abundance, commercially available sources are often expensive and subject to high 
inter-batch variability, which reduces their reliability for large-scale screening applications. In addition to the 
costly commercial sources, there are numerous protocols available for either pepsin- or acid-extraction of col-
lagen I from native sources, including the seafood industry, in the form of several fish or cephalopods9, or from 
the more common bovine or pig skin10–13. Here, we describe a collagen extraction and organotypic protocol for 
kangaroo tail, which is based on the acid-extraction technique widely applied to rat tail preparations14–18. Rat tail 
collagen I is the most common source of acid-extracted collagen I, but in the context of large-scale screening, the 
yield can present a limiting-factor. Conversely, larger kangaroo tails are readily available through online suppliers, 
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which removes the limitation on collagen supply, with the option to keep sizeable stocks for many years and 
thereby reducing batch-specific variation. Furthermore, work has previously been done using the thicker kanga-
roo tendons for ligament replacement in medical applications and hence, the optical and histological properties 
of the fresh fixed tendons are already well defined19–21. Here, we detail the step-by-step production of collagen 
I from kangaroo tail. This novel source is then used to demonstrate the widespread readouts possible using the 
pre-clinical 3D organotypic matrix platform, employed in parallel with the well-established acid-extracted rat tail 
collagen I.
This organotypic platform allows assessment of lead compounds in both the stromal compartment or in a 3D 
co-culture setting. In line with previous work, assessing changes in the stromal compartment22–25, we evaluated 
collagen deposition and remodeling in rat and kangaroo tail matrices by second harmonic generation (SHG) 
imaging, picrosirius red staining and polarized light microscopy. Similarly, we quantified the matrix stiffness and 
mechanical properties by atomic force microscopy (AFM) and matrix organization by grey-level co-occurrence 
matrix (GLCM) analysis. Beyond the previous studies, we also used scanning electron microscopy (SEM) to 
assess fibre orientation, as a readout of matrix ultrastructure.
Previous work using 3D organotypic co-cultures facilitated assessment of cancer cell clusters by immunoflu-
orescence26, allowed correlation of invasion and proliferation using Ki67 staining27 and facilitated the associa-
tion of increased metastasis to increased invasiveness27,28. In this work, we demonstrate the invasive capacity of 
cell lines derived from melanoma, triple-negative breast cancer (TNBC), squamous cell carcinoma (SCC) and 
pancreatic ductal adenocarcinoma (PDAC). We also highlight the utility of this platform for investigations into 
the invasive potential of patient-derived cell lines29, with an example given from the APGI cohort (Australian 
Pancreatic Cancer Genome Initiative30–33). Finally, we perform a proof-of-principle screen for the effects of two 
small molecule inhibitors on the invasion and proliferation of a well-established TNBC cell line. The application 
of kangaroo tail tendon collagen I to generate a novel organotypic matrix demonstrates the wealth of readouts 
possible from this easily accessible and inexpensive pre-clinical platform.
Results and Discussion
The organotypic co-culture platform was originally developed as an artificial skin model for the assessment of 
SCC invasion in a regulated 3D in vitro setting34–36. Once the pre-clinical power of the model was recognized, the 
system was further demonstrated for pancreatic cancer18,23,37–39 and since, has seen its’ application to the cancer 
field expanded by us and others3,4,40–43. The organotypic matrices applied here have two distinct stages, which are 
presented as schematics (Fig. 1a,b).
Assessment of rat and kangaroo tail matrix integrity and structure. The first stage of the organo-
typic matrix platform involves the generation of a 3D organotypic matrix (Fig. 1a). Here, stromal-ECM assess-
ment can be performed.
Isolation of collagen from kangaroo tail. The collagen requirement for larger-scale drug screening using organo-
typic matrices as a pre-clinical platform can present a significant cost. We propose an alternative source of colla-
gen from kangaroo tail, which can be purchased from online suppliers, at relatively low cost. Based on the detailed 
anatomical assessment performed by others21,44, we successfully isolated tendons from fresh frozen kangaroo 
tail. A detailed protocol for the acid-extraction is provided in the Supplementary Methods and Supplementary 
Figure S1. Collagen concentration was not significantly different between rat and kangaroo tail acid-extraction 
techniques, quantified by a Sircol™ soluble collagen assay (Fig. 1c; commercial rat tail collagen: 9.62 ± 0.61 mg/
ml, rat tail collagen: 4.33 ± 0.97 mg/ml, kangaroo tail collagen: 4.64 ± 1.23 mg/ml). This was consistent with 
the quantification of total protein levels by a modified Lowry assay45, which was also not significantly different 
(Fig. 1d; commercial rat tail collagen: 11.35 ± 0.38 mg/ml, rat tail collagen: 5.94 ± 0.73 mg/ml, kangaroo tail col-
lagen: 6.9 ± 1.02 mg/ml). These two metrics allowed assessment of collagen abundance in the respective collagen 
preparations, which again showed no significant difference between rat and kangaroo tail acid-extracted collagen 
preparations (Fig. 1e; commercial rat tail collagen: 84.78 ± 4.93%, rat tail collagen: 66.63 ± 9.87%, kangaroo tail 
collagen: 72.65 ± 11.44%). However, for both rat and kangaroo tail collagen preparations, the concentration of 
collagen and protein, and the abundance of collagen were all significantly lower than the commercial rat tail col-
lagen (Corning; Fig. 1c–e).
Application of kangaroo tail preparations to fibroblast-driven contraction. The ability of human dermal fibroblasts 
to contract collagen from rat and kangaroo tail tendons was assessed by establishment of organotypic matri-
ces (Fig. 1a). To generate organotypic matrices, telomerase-immortalized fibroblasts (TIFs)46 were embedded 
in a neutralized collagen matrix of either rat (2.5 ml) or kangaroo (5 ml) tail collagen (~1 × 105 TIFs/matrix), 
allowing them to contract this matrix over 12 days at 37 °C. This volume was initially optimized to identify the 
ideal volume of kangaroo tail collagen to reproduce similar matrix characteristics to the benchmarked rat tail 
collagen matrices (Supp. Fig. S2). By this method, kangaroo tail collagen produced a similar matrix diameter to 
the well-established rat tail organotypics (Fig. 2a)23,26,27,42,43,47,48. These organotypic matrices were then subjected 
to rigorous assessment of their ECM properties. One common assessment of ECM structure is by intrinsic mul-
tiphoton excitation of the non-centrosymmetric structure of cross-linked collagen fibres by SHG imaging49–52, 
which enables assessment of cancer therapies aimed at stromal targeting of the ECM23,53,54. Kangaroo tail matrices 
showed no significant difference in their peak SHG signal (Fig. 2b), indicating that dermal fibroblast remodel-
ling of the collagen is maintained between the preparations. Another readout possible from SHG data allows 
assessment of matrix order by GLCM analysis (Fig. 2c). GLCM is a mathematical pattern analysis technique that 
compares the brightness, or grey-level, of each pixel to neighboring pixels (Fig. 2c)22,55. In this way, the network of 
collagen fibres within the matrix can be assessed22–24,53,54 and again, no significant difference was found between 
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the rat and kangaroo tail preparations (Fig. 2c). Complementing this, we then applied AFM, a common test of 
matrix integrity that uses a nanometre tip attached to a cantilever, where changes in the position of the tip are 
detected by an optical deflection system and provide nanometer resolution for force mapping of samples53,56–59. 
Using AFM, we found no significant difference in the Young’s modulus between the rat and kangaroo tail matri-
ces (Fig. 2d)60. Taken together, these orthogonal techniques found no significant differences between the rat and 
kangaroo tail organotypic matrix preparations (Fig. 2b–d), supporting the use of this novel source of collagen I.
While a larger volume of collagen is required to produce individual kangaroo tail organotypic matrices (see 
Methods and Supp. Fig. S2), these matrices reach a similar endpoint diameter to the rat tail matrices (Fig. 2a). 
The increased volume of collagen used to generate kangaroo tail organotypic matrices of suitable diameter was 
found to result in an increased matrix thickness. To accurately measure this difference, we used the recordings 
of the z-position of the AFM probe and found that the kangaroo tail organotypic matrices were almost twice as 
thick as the rat tail matrices (Fig. 2d; rat tail collagen: 1.08 ± 0.16 mm, kangaroo tail collagen: 1.86 ± 0.34 mm). 
This prompted further analysis by SEM of the ultrastructure of the collagen fibre network, by computational 
assessment of the alignment of pixels making up collagen fibres across an entire image61,62. The peak alignment 
(measured in degrees) of fibres was determined, and the frequency of fibre alignment calculated across a degree 
range spanning the peak alignment (i.e. peak alignment ± 5°, 15°, 30° or 45°; Fig. 2e). By this method, we found 
no significant differences in rat and kangaroo tail collagen fibre alignment frequency (Fig. 2e).
Further to the optical assessment, histological sections were taken for staining of four common ECM compo-
nents; collagen types I and III, Fibronectin, Hyaluronic Acid (HA) and Laminin (Fig. 3). These ECM components 
have been shown to have a dual role in cancer, both in containment and progression63–67. Picrosirius red staining 
is a common method to identify collagens in tissue sections and has been previously applied to organotypic 
matrix sections23 and kangaroo articular cartilage and tendons19,68. In addition to transmitted light analysis, we 
applied polarized light microscopy to assess the birefringence of the picrosirius dye molecules, which allows 
differentiation between highly organized fibrillar collagen and less organized, globular collagen69,70. Following 
staining, no significant change was detected between either the coverage of the picrosirius red stained colla-
gen (transmitted light, Fig. 3a) or the proportions of higher ordered fibrillar collagens (polarized light, Fig. 3a). 
Immunohistochemical (IHC) staining for Fibronectin was also performed to assess coverage within organotypic 
matrices and showed no significant difference between the rat and kangaroo tail preparations (Fig. 3b). Similarly, 
IHC staining for HA, an important stromal-derived ECM component40,41,71,72, showed no significant difference 
in coverage between the rat and kangaroo tail organotypic matrix sections (Fig. 3c). Lastly, strong positive IHC 
Figure 1. Schematic representation of the three-dimensional (3D) organotypic matrix platform that 
demonstrates the two stages of the assay and concentration measurements from acid-extraction of collagen 
from rat and kangaroo tail tendons. (a) Stage 1 of the organotypic assay involves contraction of the rat or 
kangaroo tail collagen by fibroblasts, facilitating stromal-ECM assessment. (b) Stage 2 provides opportunities 
to assess cell invasion, proliferation and survival within a 3D co-culture environment. Application of (c) the 
SircolTM soluble collagen assay and (d) a modified Lowry assay to measure the collagen and total protein 
concentration of acid-extracted rat and kangaroo tail collagen respectively (n = 7), compared to commercial 
rat tail collagen (Corning, n = 3). (e) Values of collagen and total protein concentration from (c,d) were used to 
calculate the collagen abundance in each solution. Mean ± SD.
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Figure 2. Assessment of rat and kangaroo tail collagen matrix integrity and structure. (a) Fibroblast-driven 
matrix contraction for both rat and kangaroo tail collagens (n = 3, scale bars: 5 mm). (b) Contracted matrices 
were then subjected to second harmonic generation (SHG) imaging of collagen crosslinking (n = 3, scale bars: 
50 μm, scale bars (insets): 12.5 μm), (c) grey-level co-occurrence matrix (GLCM) analysis of matrix texture 
(n = 3), (d) atomic force microscopy (AFM) of matrix stiffness and thickness by AFM probe engagement (n = 6 
(rat) and n = 5 (kangaroo)), and (e) scanning electron microscopy (SEM) of contracted rat and kangaroo 
tail collagen matrices, assessed for changes in fibre orientation angle with the frequency of fibre alignment 
calculated across different degree ranges spanning the peak alignment (i.e. peak alignment ± 5°, 15°, 30° and 
45°; scale bars: 20 μm, n = 3). The local orientation of fibres in the rat and kangaroo tail collagen scanning 
electron micrographs is represented by the corresponding colour assigned to each specific angle of orientation. 
Mean ± SD.
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Figure 3. Immunohistochemical (IHC) staining of 12-day fibroblast contracted rat and kangaroo tail collagen 
matrices for various matrix components. (a) Picrosirius red staining (n = 3, scale bars: 100 μm) of collagen 
content (top, transmitted light imaging) or birefringence (bottom, polarized light imaging; green (low 
birefringence), yellow (medium birefringence) and red-orange (high birefringence), channels are highlighted 
for clarity). IHC staining of (b) Fibronectin and (c) Hyaluronic Acid (HA), quantified for positive staining 
coverage (n = 3, scale bars: 100 μm, scale bars (insets): 10 μm). (d) IHC staining of embedded fibroblasts for 
Laminin expression, with scoring of positive cells per 500 × 500 μm region of interest (#/ROI; n = 3, scale bars: 
100 μm, scale bars (insets): 10 μm). Mean ± SD.
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staining of the embedded fibroblasts was observed for Laminin, one of the primary components of the basement 
membrane (Fig. 3d)73,74. Scoring of cells positively stained for Laminin in 500 × 500 μm regions of interest showed 
no significant difference between the rat and kangaroo tail preparations (Fig. 3d).
This fibroblast-specific staining for Laminin prompted assessment of the stromal cells themselves (Fig. 4). 
The embedded fibroblasts are responsible for remodeling the collagen matrices and staining for key markers can 
inform on their respective activity67,75,76. Here, we quantified positive staining by counting cells in 500 × 500 μm 
regions of interest for all three markers assessed in both rat and kangaroo organotypic matrices; fibroblast activa-
tion protein (FAP), a marker of reactive stromal fibroblasts75,77,78, alpha smooth muscle actin (αSMA), a marker 
of increased contractility in myofibroblast cells56,75,76,79,80 and phosphorylated-Myosin phosphatase target subunit 
1 (phospho-MYPT1), a marker of actomyosin contractility76,81–83 (Fig. 4a–c). This affirmed that the activity of 
the stromal cells within both the rat and kangaroo tail matrices was not significantly different between the two 
preparations. Previous work has demonstrated that activated fibroblasts, which are capable of secreting their own 
ECM3,84–87, also upregulate several genes at the transcriptional level87. To confirm that these genes were similarly 
expressed in organotypic-embedded fibroblasts, within both rat and kangaroo tail organotypic matrices, quan-
titative real-time PCR (qRT-PCR) was performed on fibroblasts from 12 day contracted organotypic matrices. 
According to the MIQE guidelines88 for the analysis of qRT-PCR data by the comparative CT method89,90, a 
minimum of 2-fold difference is necessary to report differences in gene expression between treatment groups. 
The changes presented for the fibroblast markers ACTA2 (i.e. αSMA), THY1 and TGFB1 are neither statistically 
significant, nor their fold-change of a significant magnitude, to show a difference between the rat and kangaroo 
tail matrices (Fig. 4d). These genes have previously been shown to be upregulated in activated fibroblasts, along 
with COL1A1, COL1A2 and FN187. Here we saw no significant difference in these additional transcripts between 
rat and kangaroo tail matrices, even with the additional assessment of the hyaluronan synthesis genes HAS1, 
HAS2 and HAS3, and the basement membrane glycoprotein, Nidogen-1 (NID-1; Fig. 4d). This suggests that there 
is no significant difference in activation status of fibroblasts embedded in the two different matrices. Additionally, 
the GAPDH normalized results presented (Fig. 4d) were consistent with normalization to a second housekeeping 
gene RPLP0 (Supp. Fig. S3).
Targeting of the tumour stromal-ECM components is an emerging area, as their respective importance in 
both impeding drug delivery and therapeutic resistance are increasingly recognized23,25,71,72,79,91–98. Using stage 1 
(Fig. 1a) of our novel kangaroo tail organotypic matrix platform, which demonstrated similar properties to the 
well-defined rat tail organotypic matrices, could allow assessment of this stromal targeting on both the ECM and 
the associated stromal cells, as demonstrated previously23–25,47,53. Subsequent assessment of cancer cell behavior, 
either independently or in parallel with stromal-ECM modulation, is then possible by progressing to stage 2 of 
the organotypic assay (Fig. 1b).
Application of kangaroo tail collagen organotypic matrices to several common cancer models 
and patient-derived cell lines. Organotypic matrices were originally developed as models of artificial skin 
for modeling invasion of SCC34–36. The method itself involves the initial generation of an organotypic matrix 
(Fig. 1a); here using rat and kangaroo tail collagen as the substrate for TIFs. After 12 days, the matrix is sufficiently 
remodeled to allow seeding of cancer cells on the upper surface (Fig. 1b, 1 × 105 cancer cells per matrix). Once the 
seeded cells have grown to confluence, generally after 5 days, the seeded matrices are moved to an air-liquid inter-
face to allow the seeded cells to invade towards the chemoattractants in the growth media (Fig. 1b)18,34–36. In this 
work, we demonstrate invasion of cell lines from human melanoma (CHL-1, Fig. 5a), human SCC (A431, Fig. 5b) 
and mouse PDAC (KPC, Fig. 5c) that invaded on an air-liquid interface for 14 days; recapitulating previous work 
using rat tail organotypic matrices40,41,43,99,100. From here, we demonstrate key functional readouts possible from 
IHC staining, such as cell invasion using S100B/pan-cytokeratin expression, which excludes fibroblasts from 
the quantification, proliferation by Ki67 and survival by cleaved caspase-3. Invasion scoring was performed by 
first counting the cell layer adjacent to the top of the collagen matrix (non-invaded cells) and adding this value 
to the total number of cells within the matrix, to generate a percentage of invaded cells, or the “invasive index” 
(Fig. 5). This is similar to the scoring performed for proliferation or survival, where the cells that are positively 
stained for Ki67 or cleaved caspase-3 respectively (brown) are divided by the total number of cells (brown + blue), 
to generate proliferative and apoptotic indices (Fig. 5). Notably, Fig. 5 shows that for each individual cancer 
cell line, invasion, proliferation and survival were demonstrably similar between rat and kangaroo tail matrices, 
while illustrating the clear differences in 3D invasion, proliferation and survival between different cancer types. 
Importantly, we also demonstrate the translational applicability of our novel organotypic matrix platform by 
assessment of a patient-derived cell line (PDCL) from PDAC (Fig. 5d)23,33. Patient-derived xenografts and PDCL 
models are gaining momentum in the field, as they maintain the heterogeneity of patient tumours, facilitating 
more accurate pre-clinical drug screening29,98 and can be easily applied to our pre-clinical 3D organotypic plat-
form (Fig. 5d).
Finally, to confirm the pre-clinical applicability of the rat and kangaroo tail organotypic matrices, we per-
formed a proof-of-principle drug screen using the well-established human MDA-MB-231 TNBC cell line (Fig. 6). 
TNBCs are currently the only subtype of breast cancer without approved targeted therapies101 and thus, the use 
of physiologically relevant 3D models for therapeutic development could be critical to developing novel targets 
and therapies. It has previously been shown that ROCK inhibition by Y-27632 can inhibit the infiltration of 
MDA-MB-231 cells using 2D in vitro assays102–104. Conversely, the EGFR inhibitor Gefitinib has been shown 
to have potent anti-proliferative effects on MDA-MB-231 cells105–107, while the anti-invasive effect is less well 
established108–110. To quantify the changes in invasion depth upon inhibition, invaded MDA-MB-231 cells at each 
100 μm increment were divided by the number of cells on the surface of the collagen matrix, in a similar man-
ner to the invasive index calculated in Fig. 5. These values were then normalized to the vehicle (DMSO) control 
at each depth and compared between treatments. Here, we incubated the MDA-MB-231 cells on an air-liquid 
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interface for 7 days, then treated with either vehicle (DMSO) control, Y-27632 (10 μM) or Gefitinib (100 nM) and 
incubated for a further 7 days. By this approach, we confirm that inhibition of ROCK by Y-27632 reduces the 3D 
invasive ability of these cells (Fig. 6a,b). In this setting, we saw no change in proliferation following Y-27632 treat-
ment (Fig. 6c,d) in either rat or kangaroo matrices. In contrast, the EGFR inhibitor Gefitinib, showed reductions 
Figure 4. Immunohistochemical (IHC) staining of embedded fibroblasts for three key stromal markers, (a) 
fibroblast activation protein (FAP), (b) alpha smooth muscle actin (αSMA) and (c) phosphorylated myosin 
phosphatase target subunit 1 (phospho-MYPT1), scored for positive cells per 500 × 500 μm region of interest 
(#/ROI; n = 3, scale bars: 50 μm, scale bars (insets): 10 μm). Mean ± SD. (d) Quantitative real-time PCR (qRT-
PCR) analysis of relative mRNA expression, normalized to GAPDH, of genes indicative of fibroblast activity and 
matrix deposition (n = 4). ND – not detected. Mean ± SEM.
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in both the invasion and proliferation of the MDA-MB-231 cells, as they invaded into the 3D rat and kangaroo 
matrices (Fig. 6a–d), supporting the effect shown for other cancers111–113. Our data not only support the current 
canon, but also provide evidence as to the power of this 3D organotypic matrix platform for future pre-clinical 
drug screening studies, targeting either the stromal-ECM compartment or the cancer cells themselves.
Conclusions
In this work, we present a systematic comparison between the use of acid-extracted collagen I from rat and kan-
garoo tail tendons. This acts as a proof-of-concept for novel alternative collagen sources to be applied to the 3D 
pre-clinical organotypic matrix platform (Fig. 1a,b). We demonstrate assays aimed at monitoring perturbations 
in the ECM and the parallel effects on the stromal cells, responsible for the matrix contraction. Further to this, the 
invasion of four well-established cancer cell lines was demonstrated, and we highlight the use of PDCLs for future 
pre-clinical investigations. The power of this assay was then underlined using a small-scale proof-of-principle 
drug screen, confirming the anti-invasive effect of Y-27632 and establishing a dual role for Gefitinib in both inhi-
bition of invasion and proliferation in a TNBC cell line. Further development of the assay could include the use of 
transgenic, patient-matched or cancer-associated fibroblasts, which will allow specific questions to be asked about 
the stromal interactions with the ECM and the co-cultured cancer cells23,114,115. Similarly, keratinocytes have also 
been cultured above the contracted matrices from stage 1 (Fig. 1a), allowing assessment of the regenerative ability 
of skin upon various perturbations116,117. As cheaper and more convenient sources of collagen I become available, 
Figure 5. Organotypic invasion assays demonstrating the multiple readouts possible from several established 
cancer cell lines and an example patient-derived cell line (PDCL) model. Representative images and 
quantification are given for (a) melanoma (CHL-1, n = 3), (b) squamous cell carcinoma (SCC; A431, n = 3), (c) 
pancreatic ductal adenocarcinoma (PDAC; KPC, n = 3) and (d) a PDAC PDCL (n = 3). Each cell line was then 
scored for invasive cells (i, S100B/pan-cytokeratin, which excludes fibroblasts), proliferating cells (ii, Ki67) and 
apoptotic cells (iii, cleaved caspase-3). Scale bars: 100 μm. Scale bars (insets): 12.5 μm. Mean ± SEM.
www.nature.com/scientificreports/
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the pre-clinical applicability and wide variety of readouts possible from this high fidelity 3D assay will pave the 
way to its’ widespread integration into translational research in the future.
Methods
Atomic Force Microscopy (AFM). As described previously23, measurement of the matrix Young’s 
modulus was performed on a Bioscope Catalyst (Bruker) mounted on a TMC anti-vibration table (Technical 
Manufacturing Corporation), using a 1 μm spherical colloidal probe (spring constant = 0.06 N/m; Novascan). 
First, the probe was calibrated on an uncoated glass substrate, by measuring the deflection sensitivity of the probe 
in fluid and upon engagement. Prior to matrix assessment, organotypics were immobilized in a 40 mm glass 
bottom cell culture dish using a 10% agarose solution (Bioline). To determine the spring constant, a thermal tune 
sweep was performed. Indentation assessment was run on 3 different areas/matrix and 9 points/area (separated by 
35 μm) using a Peak Force Tapping mode, with an average loading force of 1 nN, prior to calculating Young’s mod-
ulus values from force curves by the Hertz spherical indentation model (AtomicJ)60. Matrix thickness was also 
calculated for each area by subtracting the z position of the point of contact between the probe and the matrix, 
and the z position of the glass bottom cell culture dish.
Cell culture and reagents. The LSL-KRasG12D/+, LSL-Trp53R172H/+, Pdx1-Cre (KPC) PDAC100, CHL-1, 
A431 and telomerase-immortalized fibroblast (TIF)46 cell lines were maintained in Dulbecco’s modified Eagle 
medium (DMEM; Gibco), while MDA-MB-231s were maintained in Roswell Park Memorial Institute (RPMI) 
1640 (Gibco), both were supplemented with 10% FBS and penicillin/streptomycin at 100 U/ml. The PDAC 
patient-derived cell line (PDCL) TKCC10 was maintained in an m199/Ham F12 media mixture, described in118. 
Commercial rat tail collagen was from Corning (354249). Y-27632 (Selleckchem, S1049) and Gefitinib (Cayman 
Chemicals, 13166) were made up as 10 mM stock solutions in DMSO.
Figure 6. An example of a small-scale pre-clinical drug screen with the TNBC breast cancer cell line 
MDA-MB-231, invading into organotypic matrices and treated for 7 days with either control (DMSO), Y-27632 
(10 μM) or Gefitinib (100 nM). Representative images are given for (a) pan-cytokeratin staining, which was 
(b) scored for invasion depth (n = 4). Representative images are also given for (c) Ki67 staining, which was (d) 
scored for proliferation (n = 4). Scale bars: 100 μm. Scale bars (insets): 12.5 μm. Mean ± SEM.
www.nature.com/scientificreports/
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Grey-level co-occurrence matrix (GLCM) analysis. To assess stromal collagen fibre organization and 
crosslinking, GLCM analysis was used to characterize the texture of the organotypic matrix samples by determin-
ing the correlation of the SHG signal intensity within the matrix, as a function of distance, where a slower decay 
shows a more organized and correlated network of collagen fibres22,53,55. SHG images were acquired with the laser 
power adjusted to give an approximately uniform intensity between images. For each matrix within a triplicate, 5 
representative regions were taken with a field-of-view of 512 × 512 μm, line averaging of 32 and a scan speed of 
400 Hz. GLCM analysis was performed using a custom Matlab script, available at https://github.com/timpsonlab/
shg-quantification-tools. The average GLCM texture parameters119 were calculated between pixel offsets in 1 pixel 
increments, up to 100 pixels, at 0°, 90°, 180° and 270° orientations. The image correlation, as a function of dis-
tance, was plotted and the mean correlation distance = ∑
∑
D d c(d )
c(d )
i i i
i i
, where di is the offset of the ith pixel and c(d) is 
the GLCM correlation, as a function of distance.
Immunohistochemistry (IHC). Organotypic matrices were fixed in 10% neutral buffered formalin, prior 
to paraffin block embedding. 4 μm sections were then either haematoxylin and eosin (H&E) stained on a Leica 
Autostainer or underwent IHC staining for cleaved caspase-3(Asp175) (Cell Signaling, 9661, 1:100), Ki67(SP6) 
(ThermoFisher Scientific, RM-9106-S1, 1:500), S100B (Dako, Z0311, 1:3000), pan-cytokeratin (Leica-Novocastra, 
NCL-C11, 1:50), Fibronectin (EP5; Santa Cruz Biotechnology, sc-8422, 1:100) or pan-Laminin (Abcam, ab11575, 
1:100). A detailed procedure for the above IHC on a Leica Bond RX is provided in the Supplementary Methods.
For the following antibodies, manual IHC staining was performed using a pH6 target retrieval solution (Dako, 
S1699) at 93 °C for 30 minutes, prior to a 10 minute cool down in running water, followed by to a 5 minute per-
oxide block (Dako, K4011) and 10 minute protein block (Dako, X0909), then overnight incubation at 4 °C with 
one of the below primary antibodies pMYPT1(Thr696) (Millipore, ABS45, 1:100), FAP (Abcam, 53066, 1:500) 
or αSMA (Abcam Australia, AB5694, 1:200). Detection was then performed using the EnVision+ System HRP 
Labeled Polymer (Dako, Anti-Rabbit, K4001) and DAB for 10 minutes. For detection of Hyaluronic Acid (HA), 
the additional use of a Biotin and Avidin Blocking System (Dako, X0590) was required, prior to a 60 minute incu-
bation with hyaluronic acid binding protein (Calbiochem, 385911, 1:300) and detection using the VECTASTAIN 
Elite ABC HRP kit (Vector Labs, PK-6100) and DAB for 10 minutes. All images were taken using an Aperio CS2 
ScanScope (Leica Biosystems). For quantification of positively staining of HA and Fibronectin in ImageJ (NIH), 
colour deconvolution was used to isolate the DAB staining prior to measurement of staining coverage. Scoring of 
pMYPT1, αSMA, FAP and Laminin staining of fibroblasts within organotypic matrix sections was performed in 
10 representative 500 × 500 μm regions for each biological replicate.
Organotypic assay. Rat or kangaroo tail tendon collagen was prepared by acid-extraction with 0.5 M acetic 
acid (see Supplementary Methods). Concentration of these collagen preparations was quantified by a SircolTM 
soluble collagen assay, as per the manufacturer’s protocol, and a modified Lowry assay, described in45. The method 
for organotypic matrix production has been described previously for rat tail collagen15,18. Using the rat tail colla-
gen matrices as a benchmark, we optimized the kangaroo tail collagen preparation volume to produce a matrix 
of similar collagen density and mechanical properties (Supp. Fig. S2). Briefly, collagen I matrices were prepared 
with acid-extracted collagen, 10X MEM (Gibco) and neutralized using sodium hydroxide, prior to addition of 
FBS containing ~1 × 105 TIFs/matrix. To maintain consistent pore sizes throughout the work, polymerization was 
allowed to occur at 37 °C12,120,121. Detached polymerized matrices (2.5 ml or 5 ml) in 6-well wells were allowed to 
contract for 12 days. For organotypic invasion assays, contracted matrices were subsequently seeded with 1 × 105 
cancer cells in complete media, which were allowed to grow to confluence over 5 days. Seeded matrices were 
then mounted on metal grids, raising to an air/liquid interface, which was fed from below by complete media; 
changed every 2 days. Matrices were fixed after 14 days (MDA-MB-231, A431, KPC and CHL-1 cells) or 21 days 
(TKCC10 cells) of invasion. For scoring, 9 representative 500 × 500 μm areas were selected from each condi-
tion and replicate. Invasive cells were identified by pan-cytokeratin or S100B staining and recorded as having 
invaded 0–100 μm, 100–200 μm and 200–300 μm and > 300 μm. The invasive index was then calculated as either 
the number of invaded cells, divided by the total number of cells (sum of invaded cells and cells on the surface of 
the matrix) or by calculating a ratio of invaded cells at each depth to the cells on the surface. The proliferative and 
apoptotic indices were taken as a ratio of Ki67 or cleaved caspase-3 positive cells respectively, divided by the total 
cell number of cells in each area.
Picrosirius red staining and quantification. 4 μm sections were taken from paraffin embedded organo-
typic matrices and underwent deparaffinisation, rehydration and staining with 0.1% picrosirius red (Polysciences), 
as per the manufacturer’s protocol. Collagen coverage was then quantified using an in-house ImageJ macro (n = 3 
matrices, 20 regions/matrix)23. Polarized light images were collected using an Olympus U-POT polarizer in 
combination with an Olympus U-ANT transmitted light analyser fitted to the microscope. Automated quanti-
tative intensity measurements of fibrillar collagen birefringent signal were carried out on polarized light images 
using ImageJ as previously described23. Briefly, for each polarized light image, Hue-Saturation-Balance (HSB) 
thresholding was applied, where 0 ≥ H ≤ 29 | 0 ≥ S ≤ 255 | 70 ≥ B ≤ 255 was used for red-orange (highly birefrin-
gent) fibres, 30 ≥ H ≤ 44 | 0 ≥ S ≤ 255 | 70 ≥ B ≤ 255 for yellow (medium birefringent) fibres and 45 ≥ H ≤ 245 | 
0 ≥ S ≤ 255 | 70 ≥ B ≤ 200 for green (low birefringent) fibres. The relative area (as a % of total fibres [0 ≥ H ≤ 245 
| 0 ≥ S ≤ 255 | 70 ≥ B ≤ 200]) was then calculated.
RNA isolation, reverse transcription and quantitative real-time PCR (qRT-PCR) experiments 
and analysis. Prior to RNA isolation, rat and kangaroo organotypic matrices were prepared as described 
above and after contracting for 12 days, were directly collected into QIAzol lysis reagent (Qiagen) in Lysing 
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Matrix S tubes (MP Biomedicals). The matrices were then disrupted using the FastPrep-24™ 5 G Homogenizer 
(MP Biomedicals). RNA samples were isolated using the miRNeasy kit (Qiagen) and reverse transcribed with 
the Transcriptor First Strand cDNA Synthesis Kit (Roche Diagnostics). cDNA was synthesized from 2 μg of 
total RNA and diluted 1:10 before any further analysis. qRT-PCR experiments were performed using the Roche 
Universal Probe Library System on a Roche LightCycler480® (Roche LifeScience). Probes and programs used for 
qRT-PCR analysis are listed in Supplementary Tables S1 and S2. Relative mRNA expression levels were normal-
ized to GAPDH or RPLP0, and quantification was performed using the comparative CT method described previ-
ously89,90, for each biological replicate. Relative expression in organotypic-embedded fibroblasts within kangaroo 
tail matrices was compared to its expression within the rat tail organotypic matrices, referred as 1. SEM of the 
ΔΔCt values was calculated according to the fold change.
Scanning Electron Microscopy (SEM) and fibre orientation analysis. Contracted collagen matrices 
were fixed with 2% glutaraldehyde, prior to step-wise dehydration in ethanol of increasing concentration (30–
100%). Samples were then subjected to CO2 critical point drying, spattered with gold and scanned on a Hitachi 
S3400 with an accelerating voltage of 15 kV. Fibre orientation analysis was performed on electron micrographs 
using an in-house ImageJ (NIH) macro, as previously described61,62. Briefly, structure tensors were derived from 
the local orientation and isotropic properties of pixels that make up collagen fibrils. Within each input image, 
these tensors were evaluated for each pixel by computing the continuous spatial derivatives in the x and y dimen-
sions using a cubic B-spline interpolation. From this, the local predominant orientation was obtained. The peak 
alignment (measured in degrees) of fibres was then determined, and the frequency of fibre alignment calculated 
across different degree ranges spanning the peak alignment (i.e. peak alignment ± 5°, 15°, 30° and 45°).
Second Harmonic Generation (SHG) imaging and analysis. SHG imaging was performed on 10% 
neutral buffered formalin fixed samples on an inverted Leica DMI 6000 SP8 confocal microscope with a 25X 
water objective. Multiphoton excitation was performed at 890 nm with a Ti:Sapphire femtosecond laser (Coherent 
Chameleon Ultra II), detecting SHG intensity with an RLD HyD detector (440/20 nm). For each matrix within a 
triplicate, 3 representative 80 μm z-stacks were taken with a field-of-view of 512 × 512 μm, a line averaging of 4, a 
scan speed of 400 Hz and a z-step size 2.52 μm. The coverage of the SHG signal was measured using ImageJ (NIH) 
across the z-stacks and the peak signal was used for comparisons between rat and kangaroo tail organotypic 
matrices. Representative SHG images were taken from the peak intensity of the z-stack, with a field-of-view of 
512 × 512 μm, a line averaging of 32 and a scan speed of 400 Hz.
Statistical analysis. Data were statistically analyzed in GraphPad Prism (GraphPad Software, Inc., CA) 
with Student’s t-tests. For normalized data, a one-sample t-test was performed against the normalized value. In all 
cases, statistical significance was given as *p < 0.05, **p < 0.01 and ***p < 0.001.
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